UB Paderborn / Katalog / Suche / in CDI

A novel biocompatible hyaluronic acid–chitosan hybrid hydrogel for osteoarthrosis therapy

International journal of pharmaceutics, 2015-04, Vol.483 (1-2), p.158-168

2015

Link zum Volltext

Verfügbarkeit prüfen

Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue

International journal of pharmaceutics: X, 2020-12, Vol.2, p.100051-100051

2020

Link zum Volltext

Verfügbarkeit prüfen

Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1b and a poly-Arg interferon beta-1b analogue

International journal of pharmaceutics, 2020-11, Vol.589, p.119913-119913, Article 119913

2020

Link zum Volltext

Verfügbarkeit prüfen

Using protease inhibitors to improve protein stability in the presence of skin: A case study on the stability of insulin like growth factor 1

European journal of pharmaceutics and biopharmaceutics, 2021-01, Vol.158, p.379-381

2021

Link zum Volltext

Verfügbarkeit prüfen

PCR-restriction-based strategies allow genotyping without sequencing of several allelic variants of the mdx mouse that carry point mutations

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S127-S127

2016

Link zum Volltext

Verfügbarkeit prüfen

Toward generating new dystrophic mouse mutants by homologous recombination using dimeric RNA-guided FokI-dCas9 nucleases

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S127-S127

2016

Link zum Volltext

Verfügbarkeit prüfen

Design and purification of active truncated phosphoinositide 3-kinase gamma protein constructs for structural studies

Protein expression and purification, 2017-07, Vol.135, p.1-7

2017

Link zum Volltext

Verfügbarkeit prüfen

WITHDRAWN: Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue

International journal of pharmaceutics: X, 2020-12, Vol.2, p.100051, Article 100051

2020

Link zum Volltext

Verfügbarkeit prüfen

Withdrawal notice to ‘WITHDRAWN: Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue’ [International Journal of Pharmaceutics 589 (2020) 119913]

International journal of pharmaceutics: X, 2020-12, Vol.2, p.100066, Article 100066

2020

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive Transdermal Iontophoretic Delivery of Biologically Active Human Basic Fibroblast Growth Factor

Molecular pharmaceutics, 2011-08, Vol.8 (4), p.1322-1331

2011

Link zum Volltext

Verfügbarkeit prüfen

Identification of aggregation breakers for bevacizumab (Avastin®) self-association through similarity searching and interaction studies

European journal of pharmaceutics and biopharmaceutics, 2013-11, Vol.85 (3), p.773-780

2013

Link zum Volltext

Verfügbarkeit prüfen

G.P.91

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.822-822

2014

Link zum Volltext

Verfügbarkeit prüfen

Lack of estrogens impairs motor function and muscle structure in dystrophic mice

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S130-S130

2016

Link zum Volltext

Verfügbarkeit prüfen

A novel oxido-viscosifying Hyaluronic Acid-antioxidant conjugate for osteoarthritis therapy: Biocompatibility assessments

European journal of pharmaceutics and biopharmaceutics, 2015-02, Vol.90, p.70-79

2015

Link zum Volltext

Verfügbarkeit prüfen

Refinement of preclinical studies for viscosupplementation therapy evaluation: Interest of complementary techniques to evaluate cartilage in a rabbit model of early osteoarthritis

Osteoarthritis and cartilage, 2015-04, Vol.23, p.A404-A404

2015

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of iPLA2β and of stretch‐activated channels by doxorubicin alters dystrophic muscle function

British journal of pharmacology, 2013-08, Vol.169 (7), p.1537-1550

2013

Link zum Volltext

Verfügbarkeit prüfen

Lack of estrogens aggravates the pathology in dystrophic mice

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S290-S290

2015

Link zum Volltext

Verfügbarkeit prüfen

novel FIP1L1-PDGFRA mutant destabilizing the inactive conformation of the kinase domain in chronic eosinophilic leukemia/hypereosinophilic syndrome

Allergy, 2009-06, Vol.64 (6), p.913-918

2009

Link zum Volltext

Verfügbarkeit prüfen

G.P.105

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.826-826

2014

Link zum Volltext

Verfügbarkeit prüfen

P.130 - Toward generating new dystrophic mouse mutants by homologous recombination using dimeric RNA-guided FokI-dCas9 nucleases

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S127-S127

2016

Link zum Volltext

Verfügbarkeit prüfen

DMD CLINICAL THERAPIES I: P.115Targeting NADPH oxidases in models of Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S64-S64

2018

Link zum Volltext

Verfügbarkeit prüfen

DMD CLINICAL THERAPIES I

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S64

2018

Link zum Volltext

Verfügbarkeit prüfen

Thermodynamics of Protein-Ligand Interactions: History, Presence, and Future Aspects

Journal of receptors and signal transduction, 2004, Vol.24 (1-2), p.1-52

2004

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias

The lancet oncology, 2003-02, Vol.4 (2), p.75-85

2003

Link zum Volltext

Verfügbarkeit prüfen

First organometallic inhibitors for human thymidine kinase: synthesis and in vitro evaluation of rhenium(I)- and technetium(I)-tricarbonyl complexes of thymidine

Journal of organometallic chemistry, 2003-02, Vol.668 (1), p.67-74

2003

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A novel biocompatible hyaluronic acid–chitosan hybrid hydrogel for osteoarthrosis therapy

Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue

Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1b and a poly-Arg interferon beta-1b analogue

Using protease inhibitors to improve protein stability in the presence of skin: A case study on the stability of insulin like growth factor 1

PCR-restriction-based strategies allow genotyping without sequencing of several allelic variants of the mdx mouse that carry point mutations

Toward generating new dystrophic mouse mutants by homologous recombination using dimeric RNA-guided FokI-dCas9 nucleases

Design and purification of active truncated phosphoinositide 3-kinase gamma protein constructs for structural studies

WITHDRAWN: Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue

Withdrawal notice to ‘WITHDRAWN: Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue’ [International Journal of Pharmaceutics 589 (2020) 119913]

Noninvasive Transdermal Iontophoretic Delivery of Biologically Active Human Basic Fibroblast Growth Factor

Identification of aggregation breakers for bevacizumab (Avastin®) self-association through similarity searching and interaction studies

G.P.91

Lack of estrogens impairs motor function and muscle structure in dystrophic mice

A novel oxido-viscosifying Hyaluronic Acid-antioxidant conjugate for osteoarthritis therapy: Biocompatibility assessments

Refinement of preclinical studies for viscosupplementation therapy evaluation: Interest of complementary techniques to evaluate cartilage in a rabbit model of early osteoarthritis

Inhibition of iPLA2β and of stretch‐activated channels by doxorubicin alters dystrophic muscle function

Lack of estrogens aggravates the pathology in dystrophic mice

novel FIP1L1-PDGFRA mutant destabilizing the inactive conformation of the kinase domain in chronic eosinophilic leukemia/hypereosinophilic syndrome

G.P.105

P.130 - Toward generating new dystrophic mouse mutants by homologous recombination using dimeric RNA-guided FokI-dCas9 nucleases

DMD CLINICAL THERAPIES I: P.115Targeting NADPH oxidases in models of Duchenne muscular dystrophy

DMD CLINICAL THERAPIES I

Thermodynamics of Protein-Ligand Interactions: History, Presence, and Future Aspects

Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias

First organometallic inhibitors for human thymidine kinase: synthesis and in vitro evaluation of rhenium(I)- and technetium(I)-tricarbonyl complexes of thymidine

Suchergebnisse filtern